SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 5 - Annual statement of changes in beneficial ownership of securities:
SEC Accession No. 0001127602-20-004705
Filing Date
2020-02-10
Accepted
2020-02-10 18:33:57
Documents
1
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT form5.html 5  
1 PRIMARY DOCUMENT form5.xml 5 5726
  Complete submission text file 0001127602-20-004705.txt   7398
Mailing Address 225 BINNEY STREET CAMBRIDGE MA 02142
Business Address 225 BINNEY STREET CAMBRIDGE MA 02142 7814642000
BIOGEN INC. (Issuer) CIK: 0000875045 (see all company filings)

IRS No.: 330112644 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences

Mailing Address C/O CELL GENESYS, INC. 500 FORBES BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address
SHERWIN STEPHEN A (Reporting) CIK: 0001079462 (see all company filings)

State of Incorp.: DE
Type: 5 | Act: 34 | File No.: 000-19311 | Film No.: 20593303